In January 2012, the National Institute for Clinical Excellence (NICE) published a new guideline on the diagnosis and management of epilepsy in adults and children in the British Medical Journal. It covers: 1. Early diagnosis of epilepsy and screening tools. 2. The first-line recommended drugs for partial seizures are carbamazepine and lamotrigine, with levetiracetam, oxcarbazepine, and sodium valproate as options when ineffective or unsuitable for application; carbamazepine, clobazam, and gabapentin can be chosen as add-on therapy for refractory partial epilepsy where first-line drug therapy is ineffective. In generalized tonic clonic seizures, the recommended first-line drug is sodium valproate, and when it is ineffective or not suitable for application, lamotrigine, carbamazepine and oxcarbazepine can be chosen; when the first-line treatment is ineffective, clobazam and levetiracetam can be chosen for add-on treatment. 4.Ketogenic diet. 5.The management of persistent status epilepticus. 6.The management of female patients with epilepsy in anticipation of pregnancy. 7. How to effectively treat patients with epilepsy with learning disabilities. 8. Treatment considerations for elderly patients with epilepsy, etc.